These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22909670)

  • 21. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
    Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
    Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
    Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal synthesis in particular types of multiple sclerosis.
    Sladkova V; Mares J; Hlustik P; Langova J; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):124-6. PubMed ID: 23073520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
    Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
    Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.
    Mandrioli J; Sola P; Bedin R; Gambini M; Merelli E
    J Neurol; 2008 Jul; 255(7):1023-31. PubMed ID: 18535872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.
    Joseph FG; Hirst CL; Pickersgill TP; Ben-Shlomo Y; Robertson NP; Scolding NJ
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):292-6. PubMed ID: 18829628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
    Frau J; Villar LM; Sardu C; Secci MA; Schirru L; Ferraro D; Coghe G; Lorefice L; Fenu G; Bedin R; Sola P; Marrosu MG; Cocco E
    J Neurol; 2018 Feb; 265(2):424-430. PubMed ID: 29273846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.
    Bosca I; Villar LM; Coret F; Magraner MJ; Simó-Castelló M; Alvarez-Cermeño JC; Casanova B
    Mult Scler; 2010 Jul; 16(7):810-5. PubMed ID: 20538705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of endogenous antiradical protective system in multiple sclerosis.
    Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
    Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    Imrell K; Greiner E; Hillert J; Masterman T
    J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds.
    Idiman E; Ozakbas S; Dogan Y; Kosehasanogullari G
    J Neuroimmunol; 2009 Jul; 212(1-2):121-4. PubMed ID: 19457560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
    Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
    Jasperse B; Jakobs C; Eikelenboom MJ; Dijkstra CD; Uitdehaag BM; Barkhof F; Polman CH; Teunissen CE
    J Neurol; 2007 May; 254(5):631-7. PubMed ID: 17415509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR peri-CSF lesions and CSF oligoclonal bands in Italian multiple sclerosis patients.
    Pichiecchio A; Tavazzi E; Maccabelli G; Ponzio M; Romani A; Schiappacassa R; Poloni GU; Franciotta D; Roccatagliata L; Bergamaschi R; Bastianello S
    Acta Neurol Scand; 2009 Oct; 120(4):242-5. PubMed ID: 19154539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
    Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
    Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.